# NIKTIMVO

NDC: 50881-034
Generic name: axatilimab-csfr
Labeler / Manufacturer: Incyte Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250115

FDA application: BLA761411

## Active ingredients

- AXATILIMAB: 9 mg/.18mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50881-034"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50881-034
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb6dba23-e7a6-4765-a1e6-b9e277ce0381